Force-introduction point in core composites and method for producing said point using reinforcement elements that traverse the thickness of the core composite

Details for Australian Patent Application No. 2004270389 (hide)

Owner Evonik Rohm GmbH

Inventors Roth, Matthias Alexander

Agent Spruson & Ferguson

Pub. Number AU-B-2004270389

PCT Pub. Number WO2005/023526

Priority 103 42 183.1 08.09.03 DE; 203 14 187.3 08.09.03 DE

Filing date 8 September 2004

Wipo publication date 17 March 2005

Acceptance publication date 30 July 2009

International Classifications

B29C 70/08 (2006.01) Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts - comprising combinations of different forms of fibrous reinforcements incorporated in matrix material, forming one or more layers, with or without non-reinforced layers

B29C 70/24 (2006.01) Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts

B29C 70/86 (2006.01) Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023526 Priority application(s): WO2005/023526

11 June 2009 Alteration of Name

  The name of the applicant has been altered to Evonik Rohm GmbH

30 July 2009 Application Accepted

  Published as AU-B-2004270389

26 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270390-Antibodies against interleukin-1 receptor and uses thereof

2004270379-Intermediate products for producing oxazolidinone-quinolone hybrids